Published in Diabetes Res Clin Pract on November 28, 2007
Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients. J Res Med Sci (2012) 1.03
Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Mol Vis (2010) 0.86
C-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction. J Pharmacol Exp Ther (2012) 0.85
Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients. PLoS One (2015) 0.82
Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure. Exp Eye Res (2015) 0.81
Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy. Eye Sci (2011) 0.80
Factor Xa and thrombin stimulate proinflammatory and profibrotic mediator production by retinal pigment epithelial cells: a role in vitreoretinal disorders? Graefes Arch Clin Exp Ophthalmol (2013) 0.80
Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells. Mol Med Rep (2012) 0.78
The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye. Mol Vis (2016) 0.76
Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future? Front Physiol (2016) 0.75
Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia. PLoS One (2016) 0.75
Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats. Invest Ophthalmol Vis Sci (2016) 0.75
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract (2002) 3.30
Effects of pitavastatin on fasting and postprandial endothelial function and blood rheology in patients with stable coronary artery disease. Circ J (2009) 1.46
Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost (2002) 1.43
Effects of submaximal exercise on blood rheology and sympathetic nerve activity. Circ J (2010) 1.42
Circulating CD34+/133+ progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention. Circ J (2010) 1.40
Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol (2004) 1.20
Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment. Int Ophthalmol (2006) 1.17
Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages. Biochem Biophys Res Commun (2004) 1.16
Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin. Proc Natl Acad Sci U S A (2010) 1.14
Pulse wave analysis and pulse wave velocity: a review of blood pressure interpretation 100 years after Korotkov. Circ J (2006) 1.14
Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. Biochem Biophys Res Commun (2004) 1.14
Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes (2007) 1.13
Age-related changes in carotid artery flow and pressure pulses: possible implications for cerebral microvascular disease. Stroke (2006) 1.08
Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med (2003) 1.07
Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes. J Biol Chem (2004) 1.05
Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection. Hypertension (2009) 1.05
CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett (2003) 1.02
Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained extremities. Circ J (2003) 1.02
Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J (2006) 1.00
Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults. Cardiovasc Diabetol (2012) 0.99
Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. Cardiovasc Diabetol (2013) 0.99
Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol Res (2004) 0.98
CD36, serves as a receptor for advanced glycation endproducts (AGE). J Diabetes Complications (2002) 0.97
Acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) is induced in monocyte-derived macrophages: in vivo and in vitro studies. Lab Invest (2003) 0.97
Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc Med (2002) 0.96
Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem (2002) 0.94
Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. J Biochem (2004) 0.94
Endothelial cell injury in venule and capillary induced by contrast ultrasonography. Ultrasound Med Biol (2002) 0.94
C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque. Atherosclerosis (2007) 0.93
Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism (2009) 0.93
Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Metabolism (2005) 0.92
Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway. Atherosclerosis (2005) 0.92
Calcification of the medial layer of the internal thoracic artery in diabetic patients: relevance of glycoxidation. J Vasc Res (2003) 0.91
Clinical and laboratory features of hyponatremia-induced myopathy. Clin Exp Nephrol (2007) 0.91
Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model. Int J Mol Med (2007) 0.91
Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J Biol Chem (2003) 0.91
Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy. Int J Cardiol (2008) 0.90
Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. Int J Cardiol (2006) 0.90
Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs. Jpn J Pharmacol (2002) 0.89
Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol (2005) 0.89
Association of body mass index with cognitive function in elderly hypertensive Japanese. Am J Hypertens (2008) 0.88
Immunohistochemical localization of advanced glycation end products in pinguecula. Graefes Arch Clin Exp Ophthalmol (2005) 0.88
An ultrasensitive enzymatic method for measuring mevalonic acid in serum. J Lipid Res (2012) 0.88
Rupture of the anterolateral papillary muscle caused by a single diagonal branch obstruction. Circ J (2002) 0.88
Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests. Endocr J (2010) 0.88
Micronutrient status of primary school girls in rural and urban areas of South Vietnam. Asia Pac J Clin Nutr (2003) 0.88
Hypertonicity regulates the aquaporin-2 promoter independently of arginine vasopressin. Nephrol Dial Transplant (2005) 0.88
Determinants of long-term mortality in patients with type B acute aortic dissection. Am J Hypertens (2009) 0.87
SIADH closely associated with non-functioning pituitary adenoma. Endocr J (2004) 0.87
Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. Am J Kidney Dis (2004) 0.87
Images in cardiovascular medicine. Bedside diagnosis of cardiac rupture by contrast echocardiography. Circulation (2005) 0.86
Nicorandil and leukocyte activation. J Cardiovasc Pharmacol (2002) 0.86
Elevation of serum adiponectin levels in Basedow disease. Metabolism (2005) 0.86
Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rat. Biochem Biophys Res Commun (2003) 0.86
The liver is the main site for metabolism of circulating advanced glycation end products. J Hepatol (2002) 0.85
Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages. Free Radic Biol Med (2002) 0.85
Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine. Cytokine (2005) 0.85
Spermine, a natural polyamine, suppresses LFA-1 expression on human lymphocyte. J Immunol (2005) 0.85
Src family kinases and nitric oxide production are required for hepatocyte growth factor-stimulated endothelial cell growth. Atherosclerosis (2003) 0.85
Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain. Pathol Int (2002) 0.85
Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract (2008) 0.84
Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett (2002) 0.84
Multi-detector computed tomography for imaging of subendocardial infarction: prediction of wall motion recovery after reperfused anterior myocardial infarction. Circ J (2004) 0.84
SIADH is only an atypical clinical feature in a patient with prolactinoma. Intern Med (2007) 0.83
Suppression of coronary atherosclerosis by helix B surface Peptide, a nonerythropoietic, tissue-protective compound derived from erythropoietin. Mol Med (2013) 0.83
Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism. J Atheroscler Thromb (2003) 0.83
Characteristics of diabetic retinopathy in SDT rats. Diabetes Metab Res Rev (2006) 0.83
Contrast-enhanced endoscopic ultrasonography improves the preoperative localization of insulinomas. Endocr J (2002) 0.83
Incomplete deficiency of hypothalamic hormones in hypothalamic hypopituitarism associated with an old traumatic brain injury. Endocr J (2009) 0.83
Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE. J Biochem (2006) 0.83
Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Endocr J (2011) 0.83
Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant (2003) 0.83
Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone. J Biochem (2004) 0.83
Effects of a distal protection device during primary stenting in patients with acute anterior myocardial infarction. Circ J (2004) 0.82
Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure. Kidney Int (2004) 0.82
Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis. Curr Opin Investig Drugs (2003) 0.82
Circulating osteocalcin is increased in early-stage diabetes. Diabetes Res Clin Pract (2011) 0.82
Fasting plasma glucose and incidence of diabetes --- implication for the threshold for impaired fasting glucose: results from the population-based Omiya MA cohort study. J Atheroscler Thromb (2009) 0.82
Hyponatremia is the valuable manifestation for initiating diagnosis of hypopituitarism in elderly. Endocr J (2012) 0.82
Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation. Atherosclerosis (2005) 0.82
Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients. J Diabetes Complications (2002) 0.82
Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation. Acta Neuropathol (2002) 0.82
Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome. Am Heart J (2007) 0.81
Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells. Biochem Biophys Res Commun (2004) 0.81
Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages. Biochem Biophys Res Commun (2004) 0.81
Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry. Lab Invest (2002) 0.81
Role of megalin in endocytosis of advanced glycation end products: implications for a novel protein binding to both megalin and advanced glycation end products. J Am Soc Nephrol (2003) 0.81